1.Xanthoma of the Achilles Tendon
Woo Koo CHUNG ; Jung Il OH ; P K MOON ; Tae Wook KIM ; Sae Jong CHUN
The Journal of the Korean Orthopaedic Association 1982;17(5):1001-1004
Xanthoma tendinosum is a hereditary lipid storage disease marked by formation of papules or nodules in the tendon, especially the extensor tendon of the hand and feet and the Achilles tendon. Xanthoma of the Achilles tendon is a rather rare, interesting orthopaedic condition that has important ramification in internal medicine and dermatology because the lesion is associated with a specific disturbance of lipid metabolism with elevated blood cholesterol level. Author present a case of bilaterally involved Achilles tendon Xanthoma. We performed subtotal resection with gastrocnemius fascial transfer on one side and total resection with peroneus brevis tendon transfer on the other side.
Achilles Tendon
;
Cholesterol
;
Dermatology
;
Foot
;
Hand
;
Internal Medicine
;
Lipid Metabolism
;
Tendon Transfer
;
Tendons
;
Xanthomatosis
2.Mortality predictors in critically ill patients with acute kidney injury requiring continuous renal replacement therapy
Kristianne Rachel P. MEDINA-LIABRES ; Jong Cheol JEONG ; Hyung Jung OH ; Jung Nam AN ; Jung Pyo LEE ; Dong Ki KIM ; Dong-Ryeol RYU ; Sejoong KIM
Kidney Research and Clinical Practice 2021;40(3):401-410
Background:
Because of high cost of continuous renal replacement therapy (CRRT) and the high mortality rate among severe acute kidney injury patients, careful identification of patients who will benefit from CRRT is warranted. This study determined factors associated with mortality among critically ill patients requiring CRRT.
Methods:
This was a retrospective observational study of 414 patients admitted to the intensive care unit of four hospitals in South Korea who received CRRT from June 2017 to September 2018. Patients were divided according to degree of fluid overload (FO) and disease severity. The Cox proportional hazards model was used to explore the effect of relevant variables on mortality.
Results:
In-hospital mortality rate was 57.2%. Ninety-day mortality rate was 58.5%. Lower creatinine and blood pH were significant predictors of mortality. A one-unit increase in the Sequential Organ Failure Assessment (SOFA) score was associated with increased risk of and 90-day mortality (hazard ratio [HR], 1.07; p < 0.001). The risk of 90-day mortality in FO patients was 57.2% (p < 0.001) higher than in those without FO. High SOFA score was associated with increased risk for 90-day mortality (HR, 1.79; p = 0.03 and HR, 3.05; p = 0.001) in patients without FO and with FO ≤ 10%, respectively. The highest mortality rates were in patients with FO > 10%, independent of disease severity.
Conclusion
FO increases the risk of mortality independent of other factors, including severity of acute illness. Prevention of FO should be a priority, especially when managing the critically ill.
3.Involvement of Protein Kinase C-delta in Vascular Permeability in Acute Lung Injury.
Jong J AHN ; Jong P JUNG ; Soon E PARK ; Minhyun LEE ; Byungsuk KWON ; Hong R CHO
Immune Network 2015;15(4):206-211
Pulmonary edema is a major cause of mortality due to acute lung injury (ALI). The involvement of protein kinase C-delta (PKC-delta) in ALI has been a controversial topic. Here we investigated PKC-delta function in ALI using PKC-delta knockout (KO) mice and PKC inhibitors. Our results indicated that although the ability to produce proinflammatory mediators in response to LPS injury in PKC-delta KO mice was similar to that of control mice, they showed enhanced recruitment of neutrophils to the lung and more severe pulmonary edema. PKC-delta inhibition promoted barrier dysfunction in an endothelial cell layer in vitro, and administration of a PKC-delta-specific inhibitor significantly increased steady state vascular permeability. A neutrophil transmigration assay indicated that the PKC-delta inhibition increased neutrophil transmigration through an endothelial monolayer. This suggests that PKC-delta inhibition induces structural changes in endothelial cells, allowing extravasation of proteins and neutrophils.
Acute Lung Injury*
;
Animals
;
Capillary Permeability*
;
Endothelial Cells
;
Lung
;
Mice
;
Mortality
;
Neutrophils
;
Protein Kinase C-delta*
;
Protein Kinases*
;
Pulmonary Edema
4.Development of Efficient Screening Methods for Hazardous HBV Virus in Vaccine Preparation.
Jung Hyun SHIM ; Kyung Ae LEE ; Jong Wan KIM ; Seung Woo NAM ; Jin ho SHIN ; Sue Nie PARK ; Yong Kweon CHO ; Do Young YOON
Journal of Bacteriology and Virology 2003;33(1):59-68
As viral vaccines sometimes induce the side effects which intimidate humans, it is urgently required to study about the side effects of viral vaccines. Most vaccines are derived from the biological forms. Hence it should be established the efficient and sensitive evaluation methods for the possibility of dangerous contaminants such as viruses and the stability of vaccines. A lots of vaccine products have been imported, or in sale or being developed in nation. Some of products may be mixed with the hazardous viruses derived from animal or human resources. Such hazardous viruses should be identified specifically and efficiently. Biological products are not permitted to distribute or obtain without presenting the result of absence experiment of hazardous viruses and prion and the validation data of inactivation experiment during processes. In order to detect viruses, there were TEM for viral particles, infectivity assays and detection methods for nucleic acids. However, these methods have defects such as insensitivity and inaccuracy. It should be considered to detect only the hazardous viruses with specificity, precision and accuracy during the processes of preparation, transportation and storage. It is noted to increase the detection limit in order to detect the minute hazardous factors during preparation processes for viral vaccines. This study is focused on the establishment of various sensitive PCR/ELISA methods for HBV virus which enhance the detection limit in order to detect the minute hazardous factors during preparation processes for viral vaccines.
Animals
;
Biological Products
;
Commerce
;
Humans
;
Limit of Detection
;
Mass Screening*
;
Nucleic Acids
;
Sensitivity and Specificity
;
Transportation
;
Vaccines
;
Viral Vaccines
;
Virion